Drug intelligence / Profile preview

sodium cromoglicate

Development stage
Unknown
Lead developer
Basic Pharma Manufacturing
Modality
Small Molecules
Administration
Intranasal, Ophthalmic
01

Overview

Sodium cromoglicate is a small molecule mast cell stabilizer developed and manufactured by Basic Pharma Manufacturing for the treatment of allergic conditions. It is formulated as a nasal spray for allergic rhinitis and as eye drops for allergic conjunctivitis. The drug acts by preventing the degranulation of sensitized mast cells, thereby inhibiting the release of histamine, leukotrienes, and other inflammatory mediators. This stabilization is thought to be mediated through the inhibition of calcium influx and potentially via agonism of the G protein-coupled receptor 35 (GPR35). As a prophylactic agent, it is most effective when used before exposure to allergens.

Brand names
Brunicrom
Other names
cromolyn sodiumdisodium cromoglycatecromoglicic acid disodium salt
02

Targets

ORAI1 (Calcium release–activated calcium channel protein 1)GPR35 (G-protein Coupled Receptor 35)ClC (CLC chloride channel family)

Beyond the preview

Go deeper on sodium cromoglicate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sodium cromoglicate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call